After an incredible run, investors are finally seeing some pain in the biotech and broader health care sector. Major biotechnology indexes were off over 4% in Wednesday trading, while the short term trend has not been favorable either.Some investors may now think that the bubble has burst for the high growth biotech sector, but there are actually still a few […]
Source: Celgene Corp.Biotech companies have been among the market’s best-performing stocks, and that means many of the industry’s top stocks have soared to lofty levels that might have kept investors on the sidelines. Since sliding markets are likely to take biotech stocks lower, investors could soon have their first chance in a long time to buy into some great companies […]
Investing.com – Investing.com — Stocks on U.S. equities markets fell slightly amid a weakening dollar, as late losses on Monday afternoon erased previous gains in morning trading.The Dow Jones Industrial Average dropped 11.61 points or 0.06% to 18,116.04, while the NASDAQ Composite index retreated from near record highs at the end of trading last week. The S&P 500 also fell […]
The biotech sector has been on a roll lately. The SPDR S&P Biotech ETF ; ;has more than tripled since the start of 2012, compared to “just” a 63% increase in the S&P 500 .Source: Jeff Kubina via Flickr .Are we in a bubble that’s about to pop? We’ll only know for sure if (when?) the sector pulls back.In the […]
Seymour warned that the fund sat in “overbought territory,” saying that it might soon pull back. Trader Brian Kelly agreed, adding that investors might want to take profits on biotech names next week.Some biotech names may not have exhausted their momentum, trader Guy Adami said. He believes that Celgene could move even higher, adding that Gilead and Amgen may have […]
No one likes the “B” word, but it’s worth asking whether we’re seeing one in large-cap biotech stocks right now.Source: ©iStock.com/AlexRathsAt first glance, it seems to be a legitimate question given how well the sector has performed in the past year. The iShares Nasdaq Biotechnology Index (ETF) (NASDAQ:IBB) has gained nearly 70% since the low of mid-April 2014, and it […]
A pause in the dollar rally helped benchmarks start the week on a positive note. The U.S. dollar weakened ahead of the Federal Open Market Committee’s meeting that is scheduled this week. Rally in international markets also boosted investor sentiment. Separately, gains among bio-tech stocks boosted the Nasdaq. Meanwhile, discouraging reports on manufacturing and housing failed to dent investor confidence.For […]
View photo.Short interest among leading biotechs and emerging pharmaceuticals increased nearly all across the board between February 13 and February 27.Leading the trend were BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Celgene Corporation (NASDAQ: CELG) and Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX).Here, Benzinga takes a quick look at how the stocks have fared recently and what analysts expects from them, followed by a […]
Biotech stocks are known for their wild ways. Over the last few years, for instance, we have witnessed dozens of small-cap companies soar — as well as sink — following pivotal clinical or regulatory catalysts.Perhaps one of the most intriguing aspects of this phenomenon is that the biggest moves tend to occur in under-the-radar biotechs. Before skyrocketing by over 300% […]
If you follow me on Twitter you will have noticed my latest tweet on what to expect during uptrends and downtrends:This is my 17th year trading the markets. The above statement is the essence of what I am experiencing on a daily basis. In order to get exposure to potential super winners you have to identify the right pond to […]
